Davis Polk advised Metalmark Capital on the deal. Metalmark Capital executed its investment of up to $50 million in Orgenesis’s U.S.-based point of care services subsidiary, Morgenesis...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here